Cargando…
Structural Mechanisms for VMAT2 inhibition by tetrabenazine
The vesicular monoamine transporter 2 (VMAT2) is a proton-dependent antiporter responsible for loading monoamine neurotransmitters into synaptic vesicles. Dysregulation of VMAT2 can lead to several neuropsychiatric disorders including Parkinson’s disease and schizophrenia. Furthermore, drugs such as...
Autores principales: | Dalton, Michael P., Cheng, Mary Hongying, Bahar, Ivet, Coleman, Jonathan A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508774/ https://www.ncbi.nlm.nih.gov/pubmed/37732203 http://dx.doi.org/10.1101/2023.09.05.556211 |
Ejemplares similares
-
The VMAT-2 Inhibitor Tetrabenazine Affects Effort-Related Decision Making in a Progressive Ratio/Chow Feeding Choice Task: Reversal with Antidepressant Drugs
por: Randall, Patrick A., et al.
Publicado: (2014) -
Tetrabenazine in the treatment of Huntington’s disease
por: Paleacu, Diana
Publicado: (2007) -
Tetrabenazine is neuroprotective in Huntington's disease mice
por: Wang, Hongyu, et al.
Publicado: (2010) -
Management of Huntington’s disease: role of tetrabenazine
por: de Tommaso, Marina, et al.
Publicado: (2011) -
Shared dynamics of LeuT superfamily members and allosteric differentiation by structural irregularities and multimerization
por: Ponzoni, Luca, et al.
Publicado: (2018)